The global ventricular hypertrophy treatment market is projected to increase dramatically in the coming years. This growth can be attributed to a mixture of factors, including an growing senior citizen population, escalating incidence of cardiovascular diseases, and advancements in therapies available. The is fueled by a need for effective treatme